• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec18
Viatris Receives FDA Approval for Generic Drug and Acceptance of New Drug Application, Japanese PMDA Accepts Application
11:59
Dec6
Viatris Inc. Completes Transaction to Receive $400 Million in Cash and Biocon Limited Shares
14:23
Nov24
Viatris Inc. to Participate in Two Healthcare Conferences
13:01
Nov18
Viatris Collaborates with Multiple Organizations to Combat Antimicrobial Resistance
15:32
Nov7
US Bank Securities Analyst Maintains Viatris Sell Rating, Target Price at $9.00
12:42
Nov6
Viatris released FY2025 Q3 earnings on November 6 During-Market EST, actual revenue USD 3.76 B (forecast USD 3.601 B), actual EPS USD -0.11 (forecast USD -0.0332)
21:00

Schedules & Filings

Schedules
Filings
Dec15
Distribution Plan(EST)

Cash dividend 0.12 USD

Nov24
Distribution Plan(EST)

Cash dividend 0.12 USD

Distribution Plan(EST)

Cash dividend 0.12 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More